Published Date: 08 Mar 2023
A groundbreaking study by the University of Bristol and the University of Essex has revealed new insights into the importance of early childhood for lung health.
Read Full NewsPeople with lower limb motor disability need tailored equipment, training, and medical oversight to boost performance while preventing upper limb overload and skin problems.
Nearly half of maternal deaths from venous thromboembolism in France over 12 years were preventable.
Nearly half of new colorectal cancer cases now occur in people younger than age 65 years, highlighting the need for earlier screening and better symptom awareness.
Tight glycemic targets in gestational diabetes can lower the risk for large-for-gestational-age births without increasing the risk for serious maternal and neonatal complications.
1.
In advanced endometrial cancer, immunocheckpoint inhibitor-chemotherapy combination improves overall survival.
2.
After targeted agents, a novel bispecific in EGFR-mutant lung cancer improves PFS.
3.
New imaging guidelines for head and neck cancers, a step toward practice change
4.
Unexplained CAR-T Death; Americans Spurn Sunscreen; Improving Diversity in Trials
5.
VP Nominee Medical Records Breached; Queen Elizabeth's Cancer; Galaxy Gas Whippets
1.
Neuroendocrine Tumors: Mechanisms of Mortality, Associated Conditions
2.
Role of Type I Interferons and KDM1B in Driving Cancer Stemness and Therapeutic Evasion
3.
Revolutionizing Oncology: AI in Radiology, Machine Learning in Pathology, and Deep Learning for Cancer Detection
4.
Case Study: Genomic Medicine in Precision Oncology
5.
Deterministic Reprogramming of Neutrophils within Tumors: A New Frontier in Cancer Research
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Efficient Management of First line ALK-rearranged NSCLC - Part II
2.
A Panel Discussion on Clinical Trial End Point for Tumor With PPS > 12 months
3.
Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias
4.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part IV
5.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation